The Indian Practitioner

The PDF file you selected should load here if your Web browser has a PDF reader plug-in installed (for example, a recent version of Adobe Acrobat Reader).

If you would like more information about how to print, save, and work with PDFs, Highwire Press provides a helpful Frequently Asked Questions about PDFs.

Alternatively, you can download the PDF file directly to your computer, from where it can be opened using a PDF reader. To download the PDF, click the Download link above.

Fullscreen Fullscreen Off

   Subscribe/Renew Journal


Multisystem Inflammatory Syndrome (MIS-A) is a hyperinflammatory condition occurring in adults with age >21 years. It is a rarely reported, potentially lethal condition observed in COVID-19 infections. We report a case of a 31-year-old young male with a history of COVID-19 infection one month prior, who presented with fever, abdominal pain, nausea and recurrent vomiting for 3 days and was eventually diagnosed with MIS-A. In adults presenting with raised inflammatory markers and multisystem involvement in a post COVID-19 infection, a high index of suspicion is required for diagnosis and prompt initiation of treatment with corticosteroids and IVIG is required for improved outcome.


Keywords

COVID-19, fever, inflammatory markers, MIS-A, acalculous cholecystitis
Subscription Login to verify subscription
User
Notifications
Font Size